Evolution of tumor cells during AsiDNA treatment results in energy exhaustion, decrease in responsiveness to signal, and higher sensitivity to the drug
Girard, Pierre‐Marie, Berthault, Nathalie, Kozlac, Maria, Ferreira, Sofia, Jdey, Wael, Bhaskara, Srividya, Alekseev, Sergey, Thomas, Frederic, Dutreix, Marie
Published in Evolutionary applications (01.08.2020)
Published in Evolutionary applications (01.08.2020)
Get full text
Journal Article
Abstract 2095: AsiDNATM, a targeted therapy with no acquired resistance
Jdey, Wael, Kozlac, Maria, Alekseev, Sergey, Johnson, Danielle, Bono, françoise, bhaskara, Srividya, thomas, frederic, Dutreix, Marie
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract 2918: Molecular analysis of the mechanism of action of AsiDNATM brings new clues on DNA damage response regulation
Berthault, Nathalie, Maria, Kozlac, Alekseev, Sergey, Girard, Pierre-Marie, Dutreix, Marie
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article